利伐沙班治疗静脉血栓需要用多久？

Rivaroxaban is a new oral anticoagulant that has many obvious advantages over other traditional drugs. It can highly selectively and directly inhibit bound or free factor Xa, thereby interrupting the endogenous and exogenous coagulation pathways, inhibiting thrombin production, and ultimately inhibiting thrombosis. Since (Xarelto) cannot directly act on already produced thrombin, physiological hemostasis is less affected by it.

The peak plasma concentration can be reached 2 to 4 hours after patients take this drug orally. It has the characteristics of strong anticoagulation such as rapid onset of action and rapid metabolism, and does not require monitoring of coagulation function. in the country, this drug was first approved for the prevention and treatment of venous thromboembolic disease. As people's understanding of it deepens, this drug is more and more widely used in clinical treatment. So how long does rivaroxaban take to treat venous thrombosis?

As a new type of anticoagulant drug, Rivaroxaban is rapidly absorbed after oral administration, with an average half-life of 7 to 13 hours. It has the advantages of high bioavailability, stable anticoagulant effect, high selectivity, and obvious therapeutic effect. Patients can benefit greatly from taking this drug consistently. Under normal circumstances, as long as there are no obvious contraindications and the instructions are strictly followed or the doctor's advice is followed, patients with indications can use rivaroxaban tablets for a long time. Based on the different conditions and constitutions of individual patients, the final length of time required to treat venous thrombosis with Bayer Rivaroxaban will vary from person to person.

A foreign study shows that intravenous thrombolysis is recommended when the plasma concentration (i.e., ng/ml, pure endovascular therapy was performed.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: